Ionis Pharmaceuticals Inc. Common Stock vs Macerich Company (The) Common Stock — how do they compare? Ionis Pharmaceuticals Inc. Common Stock trades at $42.5 (market cap $7.04B), while Macerich Company (The) Common Stock trades at $22.18 (market cap $6.39B). The key difference: Ionis Pharmaceuticals Inc. Common Stock and Macerich Company (The) Common Stock are close in size by market cap, and Macerich Company (The) Common Stock pays a 3.02% dividend while Ionis Pharmaceuticals Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Ionis Pharmaceuticals Inc. Common Stock for 0 Days and Macerich Company (The) Common Stock for 0 Days on average.
| IONS | MAC | |
|---|---|---|
Market Cap | $7.04B | $6.39B |
Volume | 2,977,440 | 2,684,151 |
Sector | Health | Real Estate |
52-Week High | $86.50 | $26.51 |
52-Week Low | $42.38 | $16.20 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $6.60B | $11.07B |
Dividend Yield | — | 3.02% |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
Ionis Pharmaceuticals Inc. is a biopharmaceutical company that develops RNA-targeted medicines using its antisense technology, with marketed treatments in neurology and cardiometabolic disease.
Read more on IONS →The Macerich Company is a real estate investment trust that owns, operates, and redevelops shopping centers concentrated in California, the Pacific Northwest, and other major US markets.
Read more on MAC →